J Clin Immunol

• 

  Publication Venue For

  • Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2)..  41:680-683. 2021
  • Correction to: Infections in Infants with SCID: Isolation, Infection Screening and Prophylaxis in PIDTC Centers..  41:498-500. 2021
  • Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers..  41:38-50. 2021
  • Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study..  41:66-75. 2021
  • Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry..  40:1124-1131. 2020
  • Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT..  40:1211-1213. 2020
  • A Case with Purine Nucleoside Phosphorylase Deficiency Suffering from Late-Onset Systemic Lupus Erythematosus and Lymphoma..  40:833-839. 2020
  • Deficiency of Adenosine Deaminase 2 (DADA2): Hidden Variants, Reduced Penetrance, and Unusual Inheritance..  40:917-926. 2020
  • Conversations with Founders of the Field of Human Inborn Errors of Immunity..  40:1-8. 2020
  • Unreported Missense Mutation in the Dimerization Domain of ADA2 Leads to ADA2 Deficiency Associated with Severe Oral Ulcers and Neutropenia in a Female Somalian Patient-Addendum to the Genotype-Phenotype Puzzle..  40:223-226. 2020
  • Homozygous Splice ADA2 Gene Mutation Causing ADA-2 Deficiency..  39:842-845. 2019
  • 30-Year Review of Pediatric- and Adult-Onset CVID: Clinical Correlates and Prognostic Indicators..  39:678-687. 2019
  • Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT..  39:653-667. 2019
  • Childhood Hodgkin Lymphoma: Think DADA2..  39:26-29. 2019
  • Warts and DADA2: a Mere Coincidence?.  38:836-843. 2018
  • ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome..  38:484-493. 2018
  • Low Serum IgE Is a Sensitive and Specific Marker for Common Variable Immunodeficiency (CVID)..  38:225-233. 2018
  • Hematopoietic Stem Cell Transplantation in ADA2 Deficiency: Early Restoration of ADA2 Enzyme Activity and Disease Relapse upon Drop of Donor Chimerism..  37:746-750. 2017
  • Two Sides of the Same Coin: Pediatric-Onset and Adult-Onset Common Variable Immune Deficiency..  37:592-602. 2017
  • Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases..  36:583-589. 2016
  • Dominant Splice Site Mutations in PIK3R1 Cause Hyper IgM Syndrome, Lymphadenopathy and Short Stature..  36:462-471. 2016
  • Deficiency of Adenosine Deaminase 2 Causes Antibody Deficiency..  36:179-186. 2016
  • Diagnosis, Treatment and Long-Term Follow Up of Patients with ADA Deficiency: a Single-Center Experience..  35:624-637. 2015
  • Disseminated Mycobacterium kansasii disease in complete DiGeorge syndrome..  35:435-438. 2015
  • Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning..  35:384-398. 2015
  • ICON: the early diagnosis of congenital immunodeficiencies..  34:398-424. 2014
  • Psychrobacter immobilis septicemia in a boy with X-linked chronic granulomatous disease and fulminant hepatic failure..  34:39-41. 2014
  • The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901..  33:1156-1164. 2013
  • Bioavailability of IgG administered by the subcutaneous route..  33:984-990. 2013
  • Post-transplantation B cell function in different molecular types of SCID..  33:96-110. 2013
  • Diagnosis of 22q11.2 deletion syndrome and artemis deficiency in two children with T-B-NK+ immunodeficiency..  32:1141-1144. 2012
  • Tolerability of a new 10% liquid immunoglobulin for intravenous use, Privigen, at different infusion rates..  30:442-448. 2010
  • Hyper IgM Syndrome: a Report from the USIDNET Registry. 2016